Susquehanna International Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-221,719
Closed -$282K 6950
2023
Q3
$282K Buy
+221,719
New +$282K ﹤0.01% 4110
2023
Q1
Hold
0
6987
2022
Q4
Hold
0
7093
2022
Q3
Sell
-10,867
Closed -$12K 7160
2022
Q2
$12K Sell
10,867
-151,779
-93% -$168K ﹤0.01% 5481
2022
Q1
$333K Sell
162,646
-209,915
-56% -$430K ﹤0.01% 4221
2021
Q4
$1.07M Buy
372,561
+235,696
+172% +$679K ﹤0.01% 2781
2021
Q3
$580K Buy
+136,865
New +$580K ﹤0.01% 3480
2021
Q2
Sell
-43,680
Closed -$203K 6098
2021
Q1
$203K Sell
43,680
-93,945
-68% -$437K ﹤0.01% 4782
2020
Q4
$454K Buy
137,625
+35,069
+34% +$116K ﹤0.01% 3509
2020
Q3
$339K Buy
102,556
+47,835
+87% +$158K ﹤0.01% 3401
2020
Q2
$184K Sell
54,721
-216,959
-80% -$730K ﹤0.01% 3755
2020
Q1
$1.04M Buy
271,680
+26,387
+11% +$101K ﹤0.01% 1993
2019
Q4
$1.48M Buy
245,293
+187,876
+327% +$1.14M ﹤0.01% 1586
2019
Q3
$434K Buy
57,417
+46,185
+411% +$349K ﹤0.01% 3052
2019
Q2
$152K Sell
11,232
-87,465
-89% -$1.18M ﹤0.01% 4018
2019
Q1
$535K Sell
98,697
-111,997
-53% -$607K ﹤0.01% 1789
2018
Q4
$625K Sell
210,694
-118,568
-36% -$352K ﹤0.01% 1919
2018
Q3
$2.69M Buy
329,262
+208,871
+173% +$1.7M ﹤0.01% 812
2018
Q2
$1.17M Buy
+120,391
New +$1.17M ﹤0.01% 1390
2018
Q1
Sell
-170,533
Closed -$2.14M 4768
2017
Q4
$2.14M Buy
+170,533
New +$2.14M ﹤0.01% 1082
2017
Q3
Hold
0
4459
2017
Q2
Hold
0
4555
2017
Q1
Hold
0
4636
2016
Q4
Hold
0
4904